StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72−0.04 (-4.65%)

Close on Nov 17, 2026Market cap $8.33MP/E –Yield –

Phio Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Phio Pharmaceuticals's revenue for the twelve months ending Dec 31, 2020 was $0, down 100.0% year over year. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $399.00K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$21.00K-84.8%
FY2018Dec 31, 2018$138.00K+820.0%
FY2017Dec 31, 2017$15.00K-21.1%
FY2016Dec 31, 2016$19.00K-44.1%
FY2015Dec 31, 2015$34.00K-91.5%
FY2013Dec 31, 2013$399.00K+311.3%
FY2012Dec 31, 2012$97.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$21.00K-8.7%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$57.00K–
Q2 FY2018Jun 30, 2018$58.00K–
Q1 FY2018Mar 31, 2018$23.00K–
Q4 FY2017Dec 31, 2017$15.00K–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Phio Pharmaceuticals figures

See a number that looks wrong?